Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 300 followers

Latest posts

Last updated 2 days ago

ARPA-H director removed by Trump administration

2 days ago

Renee Wegrzyn, Ph.D., the inaugural head of the Advanced Research Projects Agency...

Cell death biotech Kojin winds down, citing 4 funding challenges

2 days ago

Boston biotech Kojin Therapeutics is closing its doors, citing four funding challenges...

Volta Medical’s afib AI shows gains in cardiac ablation study

2 days ago

The company’s randomized clinical trial, published in Nature Medicine, tested the addition...

Boston biotech Bambusa banks $90M for next-gen bispecifics

2 days ago

Bambusa Therapeutics has raised about $90 million to build out a pipeline...

Allogene’s phase 1 lymphoma data show CAR-T could ‘leapfrog’ competition: analysts

3 days ago

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts...

Chutes & Ladders—Neumora overhauls C-suite after phase 3 flop

3 days ago

After its depression candidate failed a phase 3 trial and disappointed analysts...

Corbus posts first US data on challenger to Pfizer’s ADC Padcev

3 days ago

Corbus Pharmaceuticals has posted the first Western clinical data on its would-be...

Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome

3 days ago

A trial of Moderna’s norovirus vaccine in the U.S. has been put...

Otsuka breaks up with cancer candidates on strategic grounds

3 days ago

Otsuka has broken up with a clutch of clinical cancer candidates. The...

Genentech archives diversity reports amid site update, examines ‘potential implications of executive orders’

3 days ago

Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity...

Conduit taps Charles River to build preclinical autoimmune case for AstraZeneca diabetes asset

3 days ago

Before taking its repurposed diabetes drug candidate into a phase 2 lupus...

After AI antibodies and peptides, UW’s Baker Lab now tackles computer-generated enzymes

3 days ago

As an initial demonstration, researchers tasked their RFdiffusion AI model with generating...